Sanofi completes acquisition of Amunix
- Details
- Category: Sanofi

Sanofi unveils new corporate brand and logo - unites the company under one purpose and a single identity
- Details
- Category: Sanofi

Over the last 50 years, Sanofi has grown into a diverse, global healthcare leader, with a rich heritage of patient-centric scientific discovery.
Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
- Details
- Category: Pfizer

Amgen and Plexium announce multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies
- Details
- Category: Amgen

Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment
- Details
- Category: Pfizer

Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age
- Details
- Category: Pfizer

Leaps by Bayer leads $80M Series A financing for Cellino Biotech to autonomize stem cell therapy manufacturing
- Details
- Category: Bayer

More Pharma News ...
- Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant
- Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines
- Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant
- GSK and Vir Biotechnology announce United States government agreement to purchase additional supply of sotrovimab
- New Vaxzevria data further support its use as third dose booster
- Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
- Amgen and Arrakis Therapeutics announce multi-target collaboration to identify novel RNA degrader small molecule therapeutics